Literature DB >> 32558260

Ethmoid-to-maxillary opacification ratio: a predictor of postoperative olfaction and outcomes in nasal polyposis?

Daniel M Beswick1, Timothy L Smith2, Jess C Mace2, Jeremiah A Alt3, Nyssa F Farrell2, Vijay R Ramakrishnan1, Rodney J Schlosser4, Zachary M Soler4.   

Abstract

BACKGROUND: Inflammatory profiles for patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) vary between North American and Asian populations. An elevated ethmoid-to-maxillary (E/M) opacification ratio on preoperative imaging is associated with certain postoperative outcomes in Asian populations and populations that are non-type 2 dominant. In this study we explore this factor in North American/type 2-based populations.
METHODS: Adult patients (n = 165) from a North American population with CRSwNP who underwent endoscopic sinus surgery (ESS) were prospectively enrolled into an observational, multi-institutional study. The 22-item Sino-Nasal Outcome Test (SNOT-22), Brief Smell Identification Test (BSIT), and Lund-Kennedy (LK) endoscopic scores were obtained pre- and postoperatively. Patients were stratified according to increasing E/M ratios based on Lund-Mackay (LM) scores.
RESULTS: On average, significant within-subject postoperative improvement was found in all patients for SNOT-22 total and domain scores, and also BSIT results (p ≤ 0.019). Preoperatively, elevated E/M ratio correlated with worse BSIT scores (r = -0.343, p < 0.001). Postoperatively, elevated E/M ratio correlated with BSIT improvement (r = 0.284, p = 0.002), but did not correlate with SNOT-22 improvement or polyp recurrence. An elevated E/M ratio was associated with greater likelihood of reporting a minimal clinically important difference in BSIT scores (χ2 = 9.96, p = 0.041).
CONCLUSION: Elevated E/M ratios were found to associated with worse baseline olfaction and an increased likelihood of achieving a clinically meaningful postoperative improvement in olfaction in this North American population with CRSwNP. Elevated E/M ratios did not predict postoperative changes in SNOT-22 measures or polyp recurrence. This suggests that prognostic factors may vary according to geography and generalized inflammatory profiles (type 2 vs non-type 2) in patients with CRS.
© 2020 ARS-AAOA, LLC.

Entities:  

Keywords:  chronic disease; outcome assessment (health care); quality of life; sinusitis

Mesh:

Year:  2020        PMID: 32558260      PMCID: PMC7746627          DOI: 10.1002/alr.22625

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  33 in total

Review 1.  Chronic Rhinosinusitis in Patients with Cystic Fibrosis.

Authors:  Daniel L Hamilos
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

2.  Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis.

Authors:  Frederick Yoo; Zachary M Soler; Jennifer K Mulligan; Kristina A Storck; Jensine M Lamira; Whitney N Pasquini; Jonathan B Hill; Tegan E Noonan; Brandon J Washington; Rodney J Schlosser
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-23       Impact factor: 3.858

3.  Staging in rhinosinusitus.

Authors:  V J Lund; I S Mackay
Journal:  Rhinology       Date:  1993-12       Impact factor: 3.681

4.  Defining the minimal clinically important difference for olfactory outcomes in the surgical treatment of chronic rhinosinusitis.

Authors:  Joshua M Levy; Jess C Mace; Todd E Bodner; Jeremiah A Alt; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2017-05-26       Impact factor: 3.858

Review 5.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 6.  Staging for rhinosinusitis.

Authors:  V J Lund; D W Kennedy
Journal:  Otolaryngol Head Neck Surg       Date:  1997-09       Impact factor: 5.591

7.  Predictive significance of computed tomography in eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Yifan Meng; Hongfei Lou; Chengshuo Wang; Luo Zhang
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-05       Impact factor: 3.858

8.  Radiographic stage fails to predict symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis.

Authors:  Neil Bhattacharyya
Journal:  Laryngoscope       Date:  2006-01       Impact factor: 3.325

9.  Response shift in quality of life after endoscopic sinus surgery for chronic rhinosinusitis.

Authors:  Adam S DeConde; Todd E Bodner; Jess C Mace; Timothy L Smith
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-08       Impact factor: 6.223

10.  Does Delaying Endoscopic Sinus Surgery Adversely Impact Quality-of-Life Outcomes?

Authors:  Jeremiah A Alt; Richard R Orlandi; Jess C Mace; Zachary M Soler; Timothy L Smith
Journal:  Laryngoscope       Date:  2018-09-12       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.